Anthocyanins and their metabolites are weak inhibitors of cytochrome P450 3A4

Molecular Nutrition and Food Research

Volumn 52, Issue 12, 2008, Pages 1428-1433

  Dreiseitel, Andrea ^a   Schreier, Peter ^b   Oehme, Anett ^b   Locher, Sanja ^b   Hajak, Goeran ^a   Sand, Philipp G ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anthocyanidin; Anthocyanin; CYP3A4; Cytochrome P450; Flavonoid

Indexed keywords

ANTHOCYANIN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; ENZYME INHIBITOR;

ARTICLE; DRUG ANTAGONISM; FOOD DRUG INTERACTION; METABOLISM;

ANTHOCYANINS; CYTOCHROME P-450 CYP3A; ENZYME INHIBITORS; FOOD-DRUG INTERACTIONS;

CITRUS X PARADISI;

EID: 57549112576     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800043     Document Type: Article

References (56)

1. Davis, M. P., Homsi, J., The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine. Support. Care Cancer 2001, 9, 442-451.
2. Heim, M. H., Meyer, U. A., Evolution of a highly polymorphic human cytochrome. P450 gene cluster: CYP2D6. Genomics 1992, 14, 49-58.
3. Hutzler, J. M., Powers, F. J., Wynalda, M. A., Wienkers, L. C., Effect of carbonate anion on cytochrome P450 2D6-mediated metabolism in vitro: The potential role of multiple oxygenating species. Arch. Biochem. Biophys. 2003, 417, 165-175.
4. Guengerich, F. P., Cytochromes P450, drugs, and diseases. Mol. Interv. 2003, 3, 194-204.
5. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., Guengerich, F. P., Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 1994, 270, 414-423.
6. Girennavar, B., Jayaprakasha, G. K., Jadegoud, Y., Nagana Gowda, G. A., Patil, B. S., Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit. Bioorg. Med. Chem. 2007, 15, 3684-3691.
7. Thummel, K. E., Wilkinson, G. R., In vitro and in vivo drug interactions involving human CYP3A. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 389-430.
8. Dahan, A., Altman, H., Food-drug interaction: Grapefruit juice augments drug bioavailability - mechanism, extent and relevance. Eur. J. Clin. Nutr. 2004, 58, 1-9.
9. Spina, E., de Leon, J., Metabolic drug interactions with newer antipsychotics: A comparative review. Basic Clin. Pharmacol. Toxicol. 2007, 100, 4-22.
10. Guo, L.-Q., Fukuda, K., Ohta, T., Yamazoe, Y., Role of furanocoumarins derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab. Dispos. 2000, 28, 766-771.
11. Tassaneeyakul, W., Guo, L.-Q., Fukuda, K., Ohta, T., Yamazoe, Y., Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch. Biochem. Biophys. 2000, 378, 356-363.
12. Cooke, D., Steward, W. P., Gescher, A. J., Marczylo, T., Anthocyans from fruits and vegetables - Does bright colour signal cancer chemopreventive activity? Eur. J. Cancer 2005, 41, 1931-1940.
13. Kong, J.-M., Chia, L.-S., Goh, N.-K., Chia, T.-F., Brouillard, R., Analysis and biological activities of anthocyanins. Phytochemistry 2003, 64, 923-933.
14. Wu, X., Beecher, G. R., Holden, J. M., Haytowitz, D. B., et al., Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem. 2006, 54, 4069-4075.
15. Koponen, J. M., Happonen, A. M., Mattila, P. H., Törrönen, A. R., Contents of anthocyanins and ellagitannins in selected foods consumed in Finland. J. Agric. Food Chem. 2007, 55, 1612-1619.
16. Kühnau, J., The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev. Nutr. Diet 1976, 24, 117-191.
17. Chun, O. K., Chung, S. J., Song, W. O., Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007, 137, 1244-1252.
18. Kim, H., Yoon, Y.-J., Shon, J.-H., Cha, I.-J., et al., Inhibitory effects of fruit juices on CYP3A activity. Drug Metab. Dispos. 2006, 34, 521-523.
19. Chan, W. K., Nguyen, L. T., Miller, V. P., Harris, R. Z., Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci. 1998, 62, 135-142.
20. Rindone, J. P., Murphy, T. W., Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. Am. J. Ther. 2005, 13, 283-284.
21. Spencer, J. P. E., Chaudry, F., Pannala, A. S., Srai, S. K., et al., Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun. 2000, 272, 236-241.
22. Neto, C. C., Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseases. Mol. Nutr. Food Res. 2007, 51, 652-664.
23. Fukumoto, L. R., Mazza, G., Assessing antioxidant and prooxidant activities of phenolic compounds. J. Agric. Food Chem. 2000, 48, 3597-3604.
24. Mazza, G., Kay, C. D., Cottrell, T., Holub, B. J., Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J. Agric. Food Chem. 2002, 50, 7731-7737.
25. Zheng, W., Wang, S. Y., Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries. J. Agric. Food Chem. 2003, 51, 502-509.
26. Garcia-Alonso, M., Rimbach, G., Sasai, M., Nakahara, M., et al., Electron spin resonance spectroscopy studies on the free radical scavenging activity of wine anthocyanins and pyranoanthocyanins. Mol. Nutr. Food Res. 2005, 49, 1112-1119.
27. Rahman, M. M., Ichiyanagi, T., Komiyama, T., Hatano, Y., Konishi, T., Superoxide radical- and peroxynitrite-scavenging activity of anthocyanins; structure-activity relationship and their synergism. Free Radic. Res. 2006, 40, 993-1002.
28. Wang, H., Nair, M. G., Strasburg, G. M., Chang, Y.-C., et al., Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J. Nat. Prod. 1999, 62, 294-296.
29. Youdim, K. A., McDonald, J., Kalt, W., Joseph, J. A., Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J. Nutr. Biochem. 2002, 13, 282-288.
30. Wang, J., Mazza, G., Effects of anthocyanins and other phenolic compounds on the production of tumor necrosis factor α in LPS/IFN-γ-Activated RAW 264.7 Macrophages. J. Agric. Food Chem. 2002, 50, 4183-4189.
31. Zafra-Stone, S., Yasmin, T., Bagchi, M., Chatterjee, A., et al., Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res. 2007, 51, 675-683.
32. Duthie, S. J., Berry phytochemicals, genomic stability and cancer: Evidence for chemoprotection at several stages in the carcinogenic process. Mol. Nutr. Food Res. 2007, 51, 665-674.
33. Lau, F. C., Shukitt-Hale, B., Joseph, J. A., The beneficial effects of fruit polyphenols on brain aging. Neurobiol. Aging 2005, 26, S128-S132.
34. Kim, D.-O., Heo, H. J., Kim, Y. J., Yang, H. S., Lee, C. Y., Sweet and sour cherry phenolics and their protective effects on neuronal cells. J. Agric. Food Chem. 2005, 53, 9921-9927.
35. Kang, T. H., Hur, J. Y., Kim, H. B., Ryu, J. H., Kim, S. Y., Neuroprotective effects of the cyanidin-3-O-β-D-glucopyranoside isolated from mulberry fruit against cerebral ischemia. Neurosci. Lett. 2006, 391, 168-172.
36. Galli, R. L., Bielinski, D. F., Szprengiel, A., Shukitt-Hale, B., Joseph, J. A., Blueberry supplemented diet reverses agerelated decline in hippocampal HSP70 neuroprotection. Neurobiol. Aging 2006, 27, 344-350.
37. Joseph, J. A., Shukitt-Hale, B., Lau, F. C., Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann. NY Acad. Sci. 2007, 1100, 470-485.
38. Shukitt-Hale, B., Carey, A. N., Jenkins, D., Rabin, B. M., Joseph, J. A., Beneficial effects of fruit extracts on neuronal function and behavior in a rodent model of accelerated aging. Neurobiol. Aging 2007, 28, 1187-1194.
39. Fleschhut, J., Kratzer, F., Rechkemmer, G., Kulling, S. E., Stability and biotransformation of various dietary anthocyanins in vitro. Eur. J. Nutr. 2006, 45, 7-18.
40. Schmiedlin-Ren, P., Edwards, D. J., Fitzsimmons, M. E., He, K. et al., Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents - decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab. Dispos. 1997, 25, 1228-1233.
41. Arayne, M. S., Sultana, N., Bibi, Z., Grape fruit juice-drug interactions. Pak. J. Pharm. Sci. 2005, 18, 45-57.
42. Pronsky, Z., Crowe, Sr. J., Young, Y. S. L., Elbe, D., et al. (Eds.), Food-Medication Interactions Handbook, Food-Medication interaction, Birchrunville, PA, USA 2006.
43. Vitaglione, P., Donnarumma, G., Napolitano, A., Galvano, F., et al., Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr. 2007, 137, 2043-2048.
44. Déprez, S., Brezillon, C., Rabot, S., Philippe, C., et al., Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 2000, 130, 2733-2738.
45. Ward, N. C., Croft, K. D., Puddey, I. B., Hodgson, J. M., Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. J. Agric. Food Chem. 2004, 52, 5545-5549.
46. Aura, A.-M., Martin-Lopez, P., Anne O'Leary, K., Williamson, G. et al., In vitro metabolism of anthocyanins by human gut microflora. Eur. J. Nutr. 2005, 44, 133-142.
47. Offman, E. M., Freeman, D. J., Dresser, G. K., Munoz, C., et al., Red wine-cisapride interaction: Comparison with grapefruit juice. Clin. Pharmacol. Ther. 2001, 70, 17-23.
48. Haehner, T., Refaie, M. O., Müller-Enoch, D., Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system. Arzneimittelforschung 2004, 54, 78-83.
49. Muto, S., Fujita, K., Yamazaki, Y., Kamataki, T., Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 2001, 479, 197-206.
50. He, N., Edeki, T., The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am. J. Ther. 2004, 11, 206-212.
51. Appiah-Opong, R., Commandeur, J. N. M., van Vugt-Lussenburg, B., Vermeulen, N. P. E., Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 2007, 235, 83-91.
52. Piver, B., Berthou, F., Dreano, Y., Lucas, D., Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol. Lett. 2001, 125, 83-91.
53. Wangensteen, H., Molden, E., Christensen, H., Malterud, K. E., Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel. Eur. J. Clin. Pharmacol. 2003, 58, 663-668.
54. Milbury, P. E., Cao, G., Prior, R. L., Blumberg, J., Bioavailablility of elderberry anthocyanins. Mech. Ageing Dev. 2002, 123, 997-1006.
55. McGhie, T. K., Ainge, G. D., Barnett, L. E., Cooney, J. M., Jensen, D. J., Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J. Agric. Food Chem. 2003, 51, 4539-4548.
56. Tsukamoto, S., Aburatani, M., Yoshida, T., Yamashita, Y., et al., CYP3A4 inhibitors isolated from licorice. Biol. Pharm. Bull. 2005, 28, 2000-2002.